Drug · DIN 02469693
ORFADIN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 10, 2018; first marketed July 10, 2018.
- Drug Identification Number (DIN)
- 02469693
- Company (DIN owner)
- Swedish Orphan Biovitrum Ab (Publ)Stockholm, --, Sweden
- Schedule
- Prescription
- Dosage form
- Suspension
- Route
- Oral
- Therapeutic class (ATC)
- Nitisinone A16AX04
- Class
- Human
- Record last updated
- July 29, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| NITISINONE | 4 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 14, 2017: NOC 20058Supplement to a New Drug Submission (SNDS) · New dosage form
Other DINs named ORFADIN
- DIN 02459698 · Marketed
- DIN 02459701 · Marketed
- DIN 02459728 · Marketed
- DIN 02459736 · Marketed